plonker recommendations, page-7

I can't wait to see the coming quarterly, in what around 2 weeks time. I'll be staying up for that one, interested in hearing 2010 Relenza production and if it's increased from the late 2009 level ~190m p.a.

I can see why some people confuse Relenza with a vaccine, as it can actually prevent you getting the flu along with treating you after you get it.

If analysts think Biota makes vaccines, perhaps Biota should get into the theraputic vaccine market... VHL an obvious target in the Oz space (disclosure: I own some VHL).